Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Plos One
|
April 3, 2020
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology
Teresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.
Plos One
|
July 6, 2019
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors
Thomas W Miller, Joshua D Amason, Elsa D Garcin, et al.
Nature
|
June 24, 2008
IRF4 addiction in multiple myeloma
Arthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.
Blood
|
October 27, 2010
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
Eva Martinez-Garcia, Relja Popovic, Dong-Joon Min, et al.
The Journal of Biological Chemistry
|
April 4, 2021
Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases
Mareike Wiedmann, Patricia K Dranchak, Mahesh Aitha, et al.
Cell Chemical Biology
|
October 24, 2023
Methotrexate-based PROTACs as DHFR-specific chemical probes
Sandeep Rana, Patricia Dranchak, Jayme L Dahlin, et al.
Blood Advances
|
January 4, 2018
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
Sham Mailankody, Dickran Kazandjian, Neha Korde, et al.
Cancer Cell
|
December 16, 2010
Cooperative epigenetic modulation by cancer amplicon genes
Lixin Rui, N C Tolga Emre, Michael J Kruhlak, et al.
Nature
|
January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R Eric Davis, Vu N Ngo, Georg Lenz, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Plos One
|
April 3, 2020
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology
Teresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.
Plos One
|
July 6, 2019
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors
Thomas W Miller, Joshua D Amason, Elsa D Garcin, et al.
Nature
|
June 24, 2008
IRF4 addiction in multiple myeloma
Arthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.
Blood
|
October 27, 2010
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
Eva Martinez-Garcia, Relja Popovic, Dong-Joon Min, et al.
The Journal of Biological Chemistry
|
April 4, 2021
Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases
Mareike Wiedmann, Patricia K Dranchak, Mahesh Aitha, et al.
Cell Chemical Biology
|
October 24, 2023
Methotrexate-based PROTACs as DHFR-specific chemical probes
Sandeep Rana, Patricia Dranchak, Jayme L Dahlin, et al.
Blood Advances
|
January 4, 2018
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
Sham Mailankody, Dickran Kazandjian, Neha Korde, et al.
Cancer Cell
|
December 16, 2010
Cooperative epigenetic modulation by cancer amplicon genes
Lixin Rui, N C Tolga Emre, Michael J Kruhlak, et al.
Nature
|
January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R Eric Davis, Vu N Ngo, Georg Lenz, et al.
Page
of 2